Form 4 for TECX Tectonic Therapeutic, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0001757533-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2025-12-31 | TECX | REICIN ALISE | CEO, Dir | M - OptEx | $2.38 | +11.0K | 239.2K | +5% | +$26.1K |
| D | 2026-01-05 | 2025-12-31 | TECX | REICIN ALISE | CEO, Dir | M - OptEx | — | -11.0K | 23.0K | -32% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | M | A | 10,966 | $2.38 | 239,151 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2025-12-31 | M | D | 10,966 | — | 22,957 | D | $2.38 · — to 2031-06-27 | 10,966 Common Stock | (F3) Received in exchange for a stock option to acquire 63,478 shares of common stock pursuant to that certain merger, as more fully described on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017952/xslF345X05/form4-06242024_080648.xml (F2) The shares subject to the option vested as follows: (i) 4,079 shares on June 30, 2024; (ii) 4,078 shares on July 31, 2024, (iii) 4,078 shares on August 31, 2024, (iv) 4,079 shares on September 30, 2024, (v) 4,078 shares on October 31, 2024, (vi) 1,297 shares on November 30, 2024, (vii) 4,078 shares on January 31, 2025, (viii) 4,078 shares on February 28, 2025 and (iv) 4,078 shares on March 31, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.. |